Clinical Trials Directory

Trials / Completed

CompletedNCT01858675

Biomarkers Correlation With Volemia

Predictive Value of Biomarkers on Volemia, Extra and Intra Vascular Varation and Hydroelectrolytic Disorders in Different ICU Patients

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
66 (actual)
Sponsor
ThermoFisher Scientific Brahms Biomarkers France · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine whether the Biomarkers (pro adrenomedullin (MR proADM), pro arginin vasopressin (CT proAVP), pro atrial natriuretic peptid (MR proANP), Pro Endothelin) changes at Day 2, Day 5 and Day 7 of ICU admission are correlated with Intravascular volume assessed by Cr 51 on red blood cells (Day 2 and Day 7) and by I 125 on albumine Day 7. The correlation of these Biomarkers are also evaluted with other markers such as erythropoietin and catecholamines. 80 ICU patients are included.

Conditions

Interventions

TypeNameDescription
OTHERBiomarkers, red blood cells and plasma assessment

Timeline

Start date
2012-03-01
Primary completion
2014-11-01
Completion
2014-12-01
First posted
2013-05-21
Last updated
2014-12-03

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT01858675. Inclusion in this directory is not an endorsement.